University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
319 Ergebnisse für "complications com" unter University Hospital Zurich, Research and Education Office
Effect of High-Dosage Cholecalciferol and Extended Physiotherapy on...
... Effect of High-Dosage Cholecalciferol and Extended Physiotherapy on Complications After Hip ... Extended Physiotherapy on Complications After Hip Fracture A Randomized Controlled Trial Heike A. Bischoff ... Effect of High-Dosage Cholecalciferol and Extended Physiotherapy on Complications After Hip ... Effect of High-Dosage Cholecalciferol and Extended Physiotherapy on Complications After Hip ... Effect of High-Dosage Cholecalciferol and Extended Physiotherapy on Complications After Hip ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
1215 Ergebnisse für "complications com" unter Somagenetix
Open Intrauterine Fetal Myelomeningocele Repair: Changes in the Sur...
... Procedure and Perinatal Complications during the First 8 Years of Experience at a Single Center Kahr, Maike ... Fetal Myelomeningocele Repair: Changes in the Surgical Procedure and Perinatal Complications during the ... Com ... Complications during the First 8 Years of Experience at a Single Center - Zurich Open Repository and Archive ... Com ...
Complications following arthroscopy of the temporomandibular joint:...
... Complications following arthroscopy of the temporomandibular joint: analysis covering a 10-year ... (1.77%). Most complications were transient, consisting mainly of temporary deficits of the 5th and 7th ... Complications following arthroscopy of the temporomandibular joint: analysis covering a 10-year ... Complications following arthroscopy of the temporomandibular joint: analysis covering a 10-year ... Complications following arthroscopy of the temporomandibular joint: analysis covering a 10-year ...
SecureCell AG
8902 Urdorf, In der Luberzen 29
+41 44 732 91 00
contact@securecell.ch
Securecell is pioneering the world’s next solutions for global biotech and MedTech systems. From automated bioprocessing and smart pharmacological facilities to the transformative applications of digital technologies to help hospitals and life scientists solve next-world problems. At Securecell we believe the best future should be our next future, hence our technologies represent innovative solutions that can improve lives on a global scale.
SecureCell AG
In der Luberzen 29
8902 Urdorf
16 Ergebnisse für "complications com" unter SecureCell AG
Securecell
... patients are at risk for many unfortunate consequences: poor glycemic control with its complications, more ... ketoacidosis (DKA) and associated frequent hospitalizations. Secondary complications, including neuropathy ... with its complications, more emergency room and hospital admissions, strains on relationships, and ... complications, including neuropathy, cardiovascular disease, and retinopathy can be especially common in brittle ...
Securecell
... consequences: poor glycemic control with its complications, more emergency room and hospital admissions ... Complications 35 (2021) 107646; https://doi.org/10.1016/j.jdiacomp.2020.107646 2 Cryer, P.E., S.N. Davis, and H ... are at risk for many unfortunate consequences: poor glycemic control with its complications, more ... ketoacidosis (DKA) and associated frequent hospitalizations. Secondary complications, including neuropathy ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
356 Ergebnisse für "complications com" unter Roche Glycart AG
Roche receives first FDA clearance for urine sample type for BK vir...
... as complications due to infection after transplantation are one of the main causes of post-operative ... collected, prepared and stored urine samples. BKV can cause severe complications in immunocompromised ... infection in immunocompromised transplant patients Early detection is critical as complications due to ... samples. BKV can cause severe complications in immunocompromised transplant patients. Higher BKV DNA ...
Roche receives first FDA clearance for urine sample type for BK vir...
... Early detection is critical as complications due to infection after transplantation are one of the main ... -invasive, easily collected, prepared and stored urine samples. BKV can cause severe complications in ... complications due to infection after transplantation are one of the main causes of post-operative morbidity and ... urine samples. BKV can cause severe complications in immunocompromised transplant patients. Higher BKV ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
867 Ergebnisse für "complications com" unter University of Zurich
Effect of high-dosage cholecalciferol and extended physiotherapy on...
... Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip ... address 2 different and important complications after hip fracture. Abstract BACKGROUND: Care of elderly ... Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip ... Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip ... Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip ...
Wounds to the dorsal carpus (coronation injury) in horses: Treatmen...
... Wounds to the dorsal carpus (coronation injury) in horses: Treatment, complications and survival ... Wounds to the dorsal carpus (coronation injury) in horses: Treatment, complications and survival ... Wounds to the dorsal carpus (coronation injury) in horses: Treatment, complications and survival ... Wounds to the dorsal carpus (coronation injury) in horses: Treatment, complications and survival ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
15 Ergebnisse für "complications com" unter CSL Vifor
CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vacci...
... complications.3 SUMMIT, N.J., July 17, 2023 / PRNewswire / -- CSL Seqirus, a business of CSL (ASX:CSL), today ... influenza and its potentially life-threatening complications." CSL Seqirus is the only manufacturer to offer ... -threatening associated complications. 3 SUMMIT, N.J. , July 17, 2023 / PRNewswire / -- CSL Seqirus, a business ... complications." CSL Seqirus is the only manufacturer to offer differentiated influenza vaccine options approved ...
Vaccines | CSL
... , however, are more likely to get flu complications that can result in hospitalization and sometimes death ... , bronchitis, sinus infections and ear infections are examples of flu-related complications. Individuals 65 ... illness. Some people, however, are more likely to get flu complications that can result in hospitalization ... . Pneumonia, bronchitis, sinus infections and ear infections are examples of flu-related complications ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
89 Ergebnisse für "complications com" unter Blutspende SRK Zürich
Impact of recipient ABH secretor status on outcome in minor ABOinco...
... complications—for example, pure RBC aplasia in major ABO-incompatible HSCT or delayed hemolysis through ... complications after ABO- incompatible HSCT have been proposed, including pre- ventive measures in the recipient ... complications—for example, pure RBC aplasia in major ABO-incompatible HSCT or delayed hemolysis through ... complications after ABO- incompatible HSCT have been proposed, including pre- ventive measures in the recipient ...
Ceftriaxone-induced hemolytic anemia with severe renal failure: a c...
... to cause severe complications and fatal outcomes. Case presentation: A 76-year-old male patient was ... restricted to proper indica- tions to prevent complications such as DIIHA [9]. Case presentation In January ... to cause severe complications and fatal outcomes. Case presentation: A 76-year-old male patient was ... restricted to proper indica- tions to prevent complications such as DIIHA [9]. Case presentation In January ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1538 Ergebnisse für "complications com" unter ETH Entrepreneurship
Consequences of pseudo-participatory approaches towards post-disast...
... com ... com ...
Consequences of pseudo-participatory approaches towards post-disast...
... com ... com ...
CUTISS AG
8952 Schlieren, Grabenstrasse 11
+41 44 244 36 60
info@cutiss.swiss
After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.
CUTISS AG
Grabenstrasse 11
8952 Schlieren
13 Ergebnisse für "complications com" unter CUTISS AG
Fallstudie: denovoSkin™ in der rekonstruktiven pädiatrischen Verbre...
... Com ... Com ...
Positive Phase 2 trial interim analysis on safety and efficacy for ...
... vulnerable to complications related to scarring, such as impaired growth and mobility, and visible ... complications related to scarring, such as impaired growth and mobility, and visible disfigurement. The findings ...
Kuros Biosciences AG
8952 Schlieren, Wagistrasse 25
+41 (0)44 733 4747
Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.
Kuros Biosciences AG
Wagistrasse 25
8952 Schlieren
35 Ergebnisse für "complications com" unter Kuros Biosciences AG
Microsoft Word - Kuros_Annual Report 2022_working template RB edits.docx
... the watertight closure is compromised. Complications include increased risk of infection (meningitis ... the watertight closure is compromised. Complications include increased risk of infection (meningitis ...
